首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Clinical prognostic value of CD4+CD25+FOXP3+regulatory T cells in peripheral blood of Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma patients
【24h】

Clinical prognostic value of CD4+CD25+FOXP3+regulatory T cells in peripheral blood of Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma patients

机译:巴塞罗那临床肝癌(BCLC)B期肝细胞癌患者外周血CD4 + CD25 + FOXP3 +调节性T细胞的临床预后价值

获取原文
获取原文并翻译 | 示例
           

摘要

Background: CD4+CD25+ forkhead box P3 (FOXP3)+ regulatory T cells (Tregs) accumulate in malignant tumors and negatively regulate antitumor immunity. However, the clinical significance of Tregs in HCC remains unclear. To determine the prognostic value of Tregs, we conducted a retrospective study on 264 patients with Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma (HCC) who underwent transcatheter arterial chemoembolization (TACE).
机译:背景:CD4 + CD25 +前叉箱P3(FOXP3)+调节性T细胞(Tregs)积聚在恶性肿瘤中,并负调节抗肿瘤免疫力。但是,尚不清楚肝癌中Treg的临床意义。为了确定Treg的预后价值,我们对264例行经导管动脉化疗栓塞(TACE)的巴塞罗那临床肝癌(BCLC)B期肝细胞癌(HCC)患者进行了回顾性研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号